Degron Therapeutics
Degron Therapeutics aims to become a global leader in the discovery and development of a new class of targeted protein degradation therapeutics, small molecule molecular glue degrader (MGD) drugs. Degron has assembled a team of world-class executives and scientific leaders, bringing its scientific excellence to the identification and validation of disease targets, particularly those undruggable by conventional small molecule inhibitors, and novel selective MGD compounds to meet unmet medical needs in all therapeutic areas.
7-day free trial · no credit card
Verified contacts
9
available on Kipplo
LinkedIn employees
20
51 to 200 range
Open roles
—
no listings
Distinct roles
6
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 9 verified contacts at Degron Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
9 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Degron Therapeutics
6 distinct titles indexed · top 6 shown.
- 1associate director of translational science
- 1director of protein chemistry
- 1general manager of human resource
- 1hrm
- 1research associate
- 1vice president of chemistry
Sign up to unlock all 9 contacts at Degron Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 9 verified contacts at Degron Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.